Taranabant

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameTaranabant
Drug Alias NameTaranabantum它拉那班泰伦那班他拉纳班他雷纳班 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor inverse agonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsSmoking CessationObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme (China) LtdMerck & Co IncBanner Pharmacaps Inc +[4] 
Active IndicationsN/A
Inactive IndicationsSmoking CessationObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG